Tanya E. Keenan

3.6k citations
43 papers · 2.1k indexed · 2 hit papers · h-index 20
Topics
Cancer Immunotherapy and Biomarkers (15 papers)Cancer Genomics and Diagnostics (7 papers)Advanced Breast Cancer Therapies (5 papers)

In The Last Decade

Tanya E. Keenan

42 papers receiving 2.0k citations

Hit Papers

Role of Immunotherapy in Triple-Negative Breast Cancer201920262021202320202019100200300400

Peers

Tanya E. Keenan
Comparison fields: 5 of 120
  • Oncology 1.1k
  • Molecular Biology 425
  • Immunology 423
  • Cancer Research 388
  • Pulmonary and Respiratory Medicine 365
Replace Koen De Geest with:
Koen De Geest United States
Fang Liu China
Nicole M. Warrington Australia
Fade Mahmoud United States
Simon J. Hall United States
Koen DeGeest United States
Dimitrios C. Ziogas Greece
Diana Lüftner Germany
April Coan United States
Gianluigi Lunardi Italy
Tanya E. Keenan relative to Koen De Geest United States Koen De Geest's profile →
Citations per field
00.5×3.5×
Koen De Geest · 1×
Citations per year

Countries citing papers authored by Tanya E. Keenan

Since Specialization
Citations

This map shows the geographic impact of Tanya E. Keenan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya E. Keenan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya E. Keenan more than expected).

Fields of papers citing papers by Tanya E. Keenan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya E. Keenan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya E. Keenan. The network helps show where Tanya E. Keenan may publish in the future.

Co-authorship network of co-authors of Tanya E. Keenan

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya E. Keenan. A scholar is included among the top collaborators of Tanya E. Keenan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya E. Keenan. Tanya E. Keenan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 25
3 93
4 15
5 6
6 28
7 110
8
Genomic correlates of response to immune checkpoint blockadebreakdown →
334
9 20
10 168
11 64
12 10
13 23
14 14
15 12
16 49
17 1
18 128
19 37
20
Care of patients with type II diabetes: a study of family physicians' compliance with clinical practice guidelines.
48

About Tanya E. Keenan

Tanya E. Keenan is a scholar working on Oncology, Cancer Research and Geriatrics and Gerontology, having authored 43 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Cancer Genomics and Diagnostics (7 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (388 citations) and Immunology (423 citations). Tanya E. Keenan has collaborated with scholars based in United States, Brazil and France. Frequent co-authors include Sara M. Tolaney, Eliezer M. Van Allen, Kelly P. Burke, Elizabeth A. Mittendorf, Aditya Bardia, Areej El‐Jawahri, Jennifer S. Temel, Steven J. Isakoff, Harry VanDusen and Leif W. Ellisen. Their work appears in journals such as Nature Medicine, Nature Genetics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026